Pluristem Therapeutics (PSTI) CEO Zami Aberman To Present At Phacilitate Cell & Gene Therapy Forum 2014
1/27/2014 8:56:37 AM
HAIFA, Israel, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell product candidates, today announced the Company's Chairman and CEO, Zami Aberman, will make two presentations and speak in panel discussions at the 10th Annual Phacilitate Cell & Gene Therapy Forum. The conference will take place on January 27th through 29th, 2014 in Washington D.C.
Help employers find you! Check out all the jobs and post your resume.
comments powered by